The lack of reported CNS tumor development in FOP patients or Acvr1/Alk2 mouse models suggests that aberrant activation of this pathway is not sufficient for tumorigenesis [22]. This evidence concerns the gene ACVR1 and fibrodysplasia ossificans progressiva.